Among people with a previous heart attack or stroke, or who are at high risk for one, a daily oral medication may offer an effective alternative to injections of PCSK9 inhibitors to lower low-density ...
A new pill from Merck could change how millions of people treat high cholesterol and help prevent heart attacks and strokes without the need for injections. The drug, called enlicitide, slashes levels ...
High cholesterol is one of the most common and manageable risk factors for heart disease. Millions of adults are prescribed cholesterol-lowering drugs to reduce low-density lipoprotein (LDL) ...
Drugmaker Eli Lilly recently reported promising early results for an experimental gene-editing therapy that may reduce ...
A new daily pill could reduce bad cholesterol levels by 60%, according to a new study. Enlicitide, which was developed by Merck, lowered "bad" LDL cholesterol by more than half in a global study ...
What Is Lerochol, and Why Does It Matter? Lerochol (lerodalcibep-liga) is a new medicine approved by the FDA to help lower elevated levels of low-density lipoprotein cholesterol (LDL-C), often called ...
Among people with a previous heart attack or stroke, or who are at high risk for one, a daily oral medication may offer an effective alternative to injections of PCSK9 inhibitors to lower low-density ...
Twice a year, a nurse slides a small needle under the skin of your upper arm. Thirty seconds later, you are done. No daily alarm, no pill organizer, no refills to remember. That is the promise of ...
(CNN) — For some people with high cholesterol, making lifestyle changes and taking routine statin medications may not be sufficient to help them reach their target cholesterol levels. For these ...
The Hearty Soul on MSN
Single dose of groundbreaking treatment can cut bad cholesterol by 62%
A single infusion of VERVE-102 reduced LDL cholesterol by up to 62% in early trials. Here's what the latest cholesterol ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results